What diluent should I use to reconstitute HGH Fragment 176-191 10mg vials?

Bacteriostatic water is the preferred diluent for HGH Fragment 176-191 because its 0.9 % benzyl alcohol content inhibits microbial growth and extends the reconstituted solution's usable life to approximately 28–30 days under refrigeration at 2–8 °C. Sterile saline or plain water for injection are alternatives only when the entire vial will be used in a single session, as they carry no preservative protection.

How long can a reconstituted HGH Fragment 176-191 vial be stored in the refrigerator?

A reconstituted vial stored continuously at 2–8 °C in a dedicated refrigerator compartment — away from the door where temperature fluctuates — remains usable for up to 30 days. Exposure to temperatures above 8 °C or a single freeze-thaw cycle after reconstitution degrades the peptide structure irreversibly, so the solution should never be refrozen once mixed.

What is the correct subcutaneous injection technique for peptide administration?

Pinch a fold of abdominal skin, insert a 27–31 gauge needle at a 45-degree angle to a depth of 6–8 mm, and inject slowly. Swab the site with 70 % isopropyl alcohol beforehand and allow it to air-dry. Rotate across four abdominal quadrants across consecutive injections to prevent localised tissue irritation or lipodystrophy at repeated puncture sites.

How do I calculate the injection volume from a 10mg Bluepeps HGH Fragment 176-191 vial?

Adding 2 mL of bacteriostatic water to the 10 mg vial creates a 5,000 mcg/mL stock. A 250 mcg dose equals 0.05 mL, drawn to the 5-unit mark on a U-100 insulin syringe. This 10 mg load — the highest single-vial quantity in the Fragment 176-191 product group — supports approximately 40 individual 250 mcg injections from one vial, reducing reconstitution frequency over a full research cycle.

Why is Bluepeps HGH Fragment 176-191 supplied as a 10mg lyophilised vial rather than a pre-mixed solution?

Lyophilisation removes water under vacuum, locking the peptide in a dry, stable cake that resists degradation for up to 24 months at −20 °C or 90 days at 2–8 °C without preservatives. A pre-mixed aqueous solution would require continuous refrigeration from manufacture and would degrade significantly faster, reducing shelf life and complicating international shipping. The lyophilised format also allows researchers to choose diluent volume and concentration for their specific dosing protocol. (2) angle_used

Batch Tested

Bluepeps

HGH FRAGMENT 10mg/vial 1 Vial by Bluepeps

Name: HGH FRAGMENT
Brand: Bluepeps
SKU: PEPT-HGHF-BLU-003
Price: 52.00 EUR
Availability: InStock

HGH Fragment 176-191 is a synthetic C-terminal peptide segment derived from human growth hormone, supplied by Bluepeps as a 10 mg lyophilised vial ready for bacteriostatic-water reconstitution and subcutaneous administration. Each vial delivers a high-load 10 mg dose — the largest single-vial quantity in the Fragment 176-191 category — giving researchers the flexibility to run extended multi-week reconstitution protocols from a single unit. Batch-released quality is enforced through two independent analytical gates: reversed-phase HPLC for sequence and content verification, with a Limulus Amebocyte Lysate endotoxin screen applied to every lot before dispatch.

€52.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

10 mg per vial — highest single-unit load in the Fragment 176-191 range, reducing reconstitution frequency across extended protocols.
Batch Tested: every lot undergoes HPLC sequence verification and LAL endotoxin screening before release.
Lyophilised cake format preserves peptide integrity for up to 24 months at −20 °C without degradation.
Compatible with standard U-100 insulin syringes, enabling precise microdose calculations without specialist equipment.
Cold-chain validated dispatch packaging maintains 2–8 °C conditions from facility to end user.
Lot-specific certificate of analysis supplied with each vial, confirming active content against the declared 10 mg specification.
Single-ingredient formulation eliminates excipient variables, supporting clean and reproducible subcutaneous research protocols.

Phase	dosage	Note
Reconstitution — Initial Setup	Add 2 mL bacteriostatic water to 10 mg vial → 5,000 mcg/mL stock	Roll gently; do not shake. Label vial with reconstitution date.
Standard Research Dose	250 mcg per injection (0.05 mL / 5 IU on U-100 syringe)	Draw volume slowly; confirm no air bubbles before injection.
Twice-Daily Protocol	250 mcg morning + 250 mcg pre-training = 500 mcg/day total	Space injections at least 4 hours apart; rotate abdominal quadrant each time.
Extended Cycle Duration	Typically 8–12 weeks continuous	One 10 mg vial provides ~40 injections at 250 mcg — supports up to 20 days at twice-daily dosing.
Storage Between Injections	Refrigerate at 2–8 °C; use within 30 days of reconstitution	Never freeze reconstituted solution; discard if cloudy or particulate matter is visible.

Key takeaways

Reconstitute using bacteriostatic water to extend vial life up to 30 days.
Store reconstituted peptide strictly at 2–8 °C; never refreeze after mixing.
Inject subcutaneously at 45 degrees using a 27–31 gauge short needle.
Rotate abdominal injection sites across four quadrants each week.
Calculate doses precisely: 2 mL diluent yields 5,000 mcg/mL from this 10 mg vial.

What Is HGH Fragment 176-191 and Why Does Handling Technique Matter?

HGH Fragment 176-191 is a 16-amino-acid peptide corresponding to the C-terminal tail of human growth hormone, and its lipolytic activity is preserved entirely within that short sequence — making correct handling from vial to injection site the single most controllable variable in any research protocol. Compared to longer peptide analogues that tolerate room-temperature exposure for short periods, Fragment 176-191's relatively small molecular weight makes it especially susceptible to degradation through heat, mechanical agitation, and contaminated diluents. Bluepeps supplies this compound in a 10 mg lyophilised cake, a format that maximises shelf stability until the moment of reconstitution.

Reconstitution: Diluent Choice and Injection Volume

Bacteriostatic water (0.9 % benzyl alcohol) is the recommended diluent for HGH Fragment 176-191 because its antimicrobial properties extend in-use vial life to approximately 30 days when refrigerated at 2–8 °C. Sterile water for injection is acceptable for single-use preparation but supports no meaningful multi-dose window. Adding 2 mL of bacteriostatic water to a 10 mg vial yields a 5 mg/mL (5,000 mcg/mL) stock solution; researchers targeting a 250 mcg dose then draw 0.05 mL per injection on a standard U-100 insulin syringe. Diluent should be directed against the vial wall — never jet-streamed onto the lyophilised cake — and the vial rolled gently rather than shaken to avoid peptide aggregation.

Storage, Cold-Chain and In-Use Refrigeration

Unreconstituted vials remain stable for up to 24 months when stored at −20 °C and for approximately 90 days at 2–8 °C, according to lyophilised peptide stability data routinely cited in pharmaceutical cold-chain literature. Once reconstituted, the solution must be held continuously at 2–8 °C and used within 28–30 days; a single freeze-thaw cycle after reconstitution is sufficient to cause irreversible aggregation. Bluepeps dispatches each lot with cold-chain packaging validated to maintain the 2–8 °C envelope during transit, and a lot-specific certificate of analysis confirms HPLC-verified active content before goods leave the facility.

Subcutaneous Injection Technique

Subcutaneous administration into the abdominal pinch — the standard site for Fragment 176-191 — delivers the peptide into loose connective tissue where absorption into systemic circulation occurs over 15–30 minutes, a window consistent with published subcutaneous pharmacokinetic data for small peptides. A 27–31 gauge, 6–8 mm needle inserted at a 45-degree angle minimises injection discomfort and reduces the risk of inadvertent intramuscular delivery. The injection site should be swabbed with 70 % isopropyl alcohol and allowed to air-dry before puncture; rotating sites across four abdominal quadrants prevents localised tissue irritation across multi-week protocols.

Usage

Gather supplies: Bluepeps HGH Fragment 176-191 10 mg vial, bacteriostatic water for injection, U-100 insulin syringe (27–31 gauge, 6–8 mm needle), alcohol swabs, and a sharps container.
Swab both the vial's rubber septum and your chosen injection site with a 70 % isopropyl alcohol swab; allow both to air-dry for at least 10 seconds before proceeding.
Draw 2 mL of bacteriostatic water into the syringe, then insert the needle at an angle against the inner vial wall — not directly onto the lyophilised cake — and release the liquid slowly to avoid foaming.
Roll the vial gently between your palms for 30–60 seconds until the cake dissolves fully into a clear, colourless solution; do not vortex or shake, as mechanical agitation damages peptide structure.
Draw your calculated dose (e.g., 0.05 mL for 250 mcg), expel any air bubble, and pinch a fold of abdominal skin; insert the needle at 45 degrees to 6–8 mm depth and inject slowly over 5–10 seconds.
Withdraw the needle, apply gentle pressure with a clean swab (do not rub), dispose of the syringe in a sharps container, and return the reconstituted vial to the refrigerator at 2–8 °C immediately.

Warnings

Contraindications: HGH Fragment 176-191 is not indicated for use in individuals with active malignancy, known hypersensitivity to any component of the formulation, or those who are pregnant or breastfeeding. Research use is strictly restricted to qualified investigators operating within applicable regulatory frameworks.

Side Effects: Reported reactions include transient localised erythema or mild induration at the injection site, particularly when site rotation is neglected. Headache and transient hypoglycaemia have been noted at doses exceeding standard research parameters. Systemic reactions are rare when aseptic technique and refrigerated storage protocols are followed correctly.

Monitoring: Verify vial solution clarity before every injection; discard any vial showing particulate matter, cloudiness, or discolouration. Monitor for injection-site reactions across the first two weeks of a new protocol. Document reconstitution date on each vial and track cumulative days in use against the 30-day refrigerated stability window.

PCT: HGH Fragment 176-191 does not suppress the hypothalamic-pituitary-gonadal axis; no post-cycle therapy targeting HPTA recovery is required following use of this peptide as a standalone compound. Researchers combining it with androgens or GH secretagogues should apply PCT according to the requirements of those co-administered compounds.

Frequently asked questions

What diluent should I use to reconstitute HGH Fragment 176-191 10mg vials?: Bacteriostatic water is the preferred diluent for HGH Fragment 176-191 because its 0.9 % benzyl alcohol content inhibits microbial growth and extends the reconstituted solution's usable life to approximately 28–30 days under refrigeration at 2–8 °C. Sterile saline or plain water for injection are alternatives only when the entire vial will be used in a single session, as they carry no preservative protection.
How long can a reconstituted HGH Fragment 176-191 vial be stored in the refrigerator?: A reconstituted vial stored continuously at 2–8 °C in a dedicated refrigerator compartment — away from the door where temperature fluctuates — remains usable for up to 30 days. Exposure to temperatures above 8 °C or a single freeze-thaw cycle after reconstitution degrades the peptide structure irreversibly, so the solution should never be refrozen once mixed.
What is the correct subcutaneous injection technique for peptide administration?: Pinch a fold of abdominal skin, insert a 27–31 gauge needle at a 45-degree angle to a depth of 6–8 mm, and inject slowly. Swab the site with 70 % isopropyl alcohol beforehand and allow it to air-dry. Rotate across four abdominal quadrants across consecutive injections to prevent localised tissue irritation or lipodystrophy at repeated puncture sites.
How do I calculate the injection volume from a 10mg Bluepeps HGH Fragment 176-191 vial?: Adding 2 mL of bacteriostatic water to the 10 mg vial creates a 5,000 mcg/mL stock. A 250 mcg dose equals 0.05 mL, drawn to the 5-unit mark on a U-100 insulin syringe. This 10 mg load — the highest single-vial quantity in the Fragment 176-191 product group — supports approximately 40 individual 250 mcg injections from one vial, reducing reconstitution frequency over a full research cycle.
Why is Bluepeps HGH Fragment 176-191 supplied as a 10mg lyophilised vial rather than a pre-mixed solution?: Lyophilisation removes water under vacuum, locking the peptide in a dry, stable cake that resists degradation for up to 24 months at −20 °C or 90 days at 2–8 °C without preservatives. A pre-mixed aqueous solution would require continuous refrigeration from manufacture and would degrade significantly faster, reducing shelf life and complicating international shipping. The lyophilised format also allows researchers to choose diluent volume and concentration for their specific dosing protocol. (2) angle_used

Manufacturer

Bluepeps' product portfolio spans a targeted range of research-grade single-ingredient peptides — HGH Fragment 176-191 among them — each positioned to address a discrete mechanistic application rather than duplicating broad-spectrum formulations. Within this catalogue, analytical consistency is enforced through a two-stage release protocol applied uniformly across all peptide lines: reversed-phase HPLC confirms both amino-acid sequence fidelity and active-content accuracy against declared specifications, while a Limulus Amebocyte Lysate endotoxin assay quantifies residual pyrogenic load to defined safety thresholds. The 10 mg HGH Fragment 176-191 vial represents one of the higher-concentration entries across Bluepeps' lyophilised peptide range, designed specifically to support extended multi-dose research protocols without requiring frequent reconstitution cycles. A lot-specific certificate of analysis is generated and attached to each batch before release, giving end users traceable documentation linked directly to the individual vial's analytical results.

Product details

Brand	Bluepeps
Active ingredient	hgh fragment 176-191
Also known as	Frag 176-191, AOD-Fragment, Bio-Peptide HGH Fragment, HGH FRAGMENT, Bluepeps Frag 176-191
Strength	10 mg
Form	Vial
Pack size	1 piece
Item number	PEPT-HGHF-BLU-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Lab Tested

HGH Fragment 5mg/vial 1 Vial by Bio-Peptide

HGH Fragment (176-191) is the synthetically produced C-terminal peptide spanning residues 176 to 191 of the human growth hormone sequence, supplied by Bio-Peptide as a lyophilised powder at 5 mg per vial, and designed to deliver selective lipolytic activity without engaging the anabolic or mitogenic pathways of full-length GH. Retaining only the fat-signalling region of the HGH molecule, this fragment promotes adipose tissue breakdown at a cellular level while leaving IGF-1 output and skeletal growth mechanisms entirely undisturbed. Each production batch is cleared through third-party HPLC sequence and purity analysis alongside LAL endotoxin screening before any vial is released for distribution.

€38.00

HPLC Verified

HGH Fragment 176-191 5mg/vial 1 Vial by Knoll Pharmaceuticals

HGH Fragment 176-191 is a 16-amino-acid peptide derived from the C-terminus of human growth hormone, supplied by Knoll Pharmaceuticals as a lyophilised powder at 5 mg per vial, and structured specifically for practitioners building lipolysis-focused dosing protocols around a caloric deficit. Unlike full-sequence GH, this fragment drives fatty acid mobilisation from adipose tissue without triggering anabolic or glucose-regulatory cascades, making dose timing relative to meals and training sessions the central variable in protocol design. Batch purity and identity are certified through HPLC chromatography; endotoxin safety is confirmed via LAL assay — both clearances are mandatory before any vial leaves Knoll Pharmaceuticals' production line.

€30.00

Top Seller

HGH 176-191 5mg/vial 1 Vial by Master Pharma

HGH Fragment 176-191 (amino acids 176–191 of the human growth hormone chain) is a lyophilised research peptide supplied by Master Pharma at 5 mg per vial — making it one of the most precise-entry concentrations available for athletes integrating peptides during a bridge or PCT phase without triggering hypothalamic-pituitary-gonadal axis suppression. Unlike growth hormone secretagogues, this fragment does not stimulate GH pulsatility or insulin-like growth factor release, leaving endogenous hormonal recovery undisturbed. Quality is anchored at the batch level: HPLC potency confirmation and LAL endotoxin testing are completed lot-by-lot before release, with certificates traceable to each vial.

€32.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00